Pulse Oximeter Market - Historic Data (2019-2024), Global Trends 2025, Growth Forecasts 2037
Pulse Oximeter Market in 2025 is evaluated at USD 2.25 billion. The global market size exceeded USD 2.18 billion in 2024 and is projected to expand at a CAGR of more than 4.3%, crossing USD 3.77 billion by 2037. Asia Pacific is forecasted to capture the dominant share, impelled by rising respiratory disease prevalence and new product launches.
The market growth is attributed to increasing prevalence of chronic respiratory diseases. According to the World Health Organization, 455 000 individuals died from asthma in 2019, which is estimated to have affected 262 million people. Moreover, growing prevalence of target diseases, and accessibility of new products are some other major factors driving the market revenue. Further, growing prevalence of diabetes will boost the market growth. According to the World Health Organization, age-specific diabetes mortality rates increased by 3% between 2000 and 2019.
Pulse Oximeter Sector: Growth Drivers and Challenges
Growth Drivers
- Growing prevalence of Lung Cancer – For instance, 121,680 men and 112,350 women were expected to have had lung cancer in the US in 2018, totaling 234,030 cases, or 641 cases per day. Red blood cells, which carry oxygen from the lungs to the heart and the rest of the body, could be reduced by lung cancer. Hence to determine the blood's oxygen saturation level, pulse oximetry is utilized. Therefore, the market is expected to grow for the forecast period owing to this factor.
- Surge in COPD Cases - Globally, approximate 210 million cases of COPD were documented in 2019, and the disease was responsible for about 2 million fatalities and approximate 73 million DALYs.
- Growing Geriatric Population - According to the World Health Organization, the number of persons in the globe who are 60 years or older will double by 2050. (2.1 billion).
- Increasing Prevalence of Chronic Disease - It was estimated that, the number of Americans with chronic diseases would rise by about 45 million, or approximate 36 percent, between 2000 and 2030.
- Technology Advancement - Researchers from the Universities of California, San Diego, and Washington have demonstrated that cell phones can detect blood oxygen saturation levels as low as 70%. The U.S. Food and Drug Administration advises that pulse oximeters be capable of measuring no less than this level.
Challenges
- Regulation & Accuracy Concerns – Factors such as skin temperature, blood circulation, and dark skin pigmentation majorly effect the accuracy rate of oximeters. Besides this, OTC pulse oximeters do not require FDA approval and people purchase them without a prescription from any pharmacy. However, there are issues with the reliability and safety of over-the-counter pulse oximeters. Hence, these factors are expected to hinder the growth of the market.
- Lack of Awareness
- Increased Pressure on Key Players
Pulse Oximeter Market: Key Insights
|
Base Year |
2024 |
|
Forecast Year |
2025-2037 |
|
CAGR |
4.3% |
|
Base Year Market Size (2024) |
USD 2.18 billion |
|
Forecast Year Market Size (2037) |
USD 3.77 billion |
|
Regional Scope |
|
Pulse Oximeter Segmentation
End-user (Hospitals & Clinics, Homecare)
The hospitals & clinics segment is anticipated to garner the largest revenue by the end of 2037, backed by growing number of surgeries and emergency room visit. For instance, over 1 million surgical procedures were performed at hospitals that were registered in 2021. Besides this, notably increasing prevalence of various chronic disorders such as asthma, cardiovascular and pneumonia is fueling the market growth.
Our in-depth analysis of the global market includes the following segments:
|
By Product Type |
|
|
By Technology |
|
|
By Age Group |
|
|
By End-use |
|
Want to customize this research report as per your requirements? Our research team will cover the information you require to help you take effective business decisions.
Customize this ReportPulse Oximeter Industry - Regional Synopsis
The Asia Pacific pulse oximeter market is set to account for majority revenue share by 2037, owing to growing prevalence of respiratory diseases, followed by the new product launches in the region. For instance, with more than 2 million cases, the Indian state of Rajasthan experienced the greatest prevalence of acute respiratory infections in 2020. Moreover, strong focus of governments of emerging nations on improving healthcare infrastructure will propel the market growth in the region.
Companies Dominating the Pulse Oximeter Landscape
- Medtronic
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Becton Dickinson and Company
- GE Healthcare
- Koninklijke Philips N.V.
- Masimo
- CAS Medical Systems, Inc.
- Opto Circuits India Limited
- Nonin Medical, Inc.
- ICU Medical, Inc.
- Welch Allyn
In the News
-
Medtronic’s Nellcor Bedside SpO2 pulse oximeter is claimed to provide faster stable oxygen saturation readings in mewborns than any other oximeter.
-
Masimo and Philips reinforced a partnership to bring Maximo NomoLine capnography and O3 regional oximetry to select Philips patient monitors.
Author Credits: Radhika Pawar
- Report ID: 3120
- Published Date: Apr 18, 2025
- Report Format: PDF, PPT
